Kennesaw University Investigator Renews NSF Grant Targeting DNA Research

Kennesaw University Investigator Renews NSF Grant Targeting DNA Research

Progressing the knowledge associated with genetic functions as well as specific proteins known as transcription factors—able to promote or suppress specific genes throughout the life of cells and organisms—combined with a growing ability to turn on or off various gene expressions leads to the opportunity to create new medical therapies. That’s why funding this type of research powers this gene therapy-based future, from small studies to major programs—all this research can contribute to a greater body of cell therapy knowledge. Now thanks to a $300,000 grant from the National Science Foundation, an associate professor of biochemistry at Kennesaw State University can continue this important research. The monies will help Michael Van Dyke employ undergraduate researchers, expanding the body of knowledge and providing training for the next life science, gene-therapy-focused labor force.

Caltech trained Professor Van Dyke’s first study commenced thanks to an NSF grant back in 2017 but expired just at the end of June. Now the Georgia-based public research university professor can continue the investigation.

The Focus

In this line of study, the Kennesaw University researcher ce...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee